Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study-Reference-Cited by-同舟云学术

Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study

Published:2023-01 Issue: Volume:Volume 16 Page:27-38
ISSN:1178-7015
Container-title:Clinical, Cosmetic and Investigational Dermatology
language:en
Short-container-title:CCID

Author:

Stingeni Luca^ORCID,Malara Giovanna,Conti Andrea,Di Costanzo Luisa,Carrera Carlo Giovanni,Burlando Martina,Malagoli Piergiorgio,Musumeci Maria Letizia,Bardazzi Federico,Brazzelli Valeria,Amerio Paolo^ORCID,De Simone Clara^ORCID,Trevisini Sara,Balato Anna,Megna Matteo,Loconsole Francesco,De Felice Catia,Bartezaghi Marta,Rausa Alice,Aloisi Elisabetta,Orsenigo Roberto,Costanzo Antonio

Publisher

Informa UK Limited

Subject

Dermatology

Reference25 articles.

1. Psoriasis

3. Severity of Psoriasis Differs Between Men and Women: A Study of the Clinical Outcome Measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish Register Patients

4. A Retrospective Study of Patients with Psoriasis Treated with Biologics: Relation to Body Mass Index and Gender

5. Sex‐ and gender‐associated clinical and psychosocial characteristics of patients with psoriasis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with a better treatment efficacy among psoriasis patients: a study based on decision tree model and logistic regression in Shanghai, China;BMC Public Health;2024-07-18

2. Paradoxical reaction to IL-17A inhibitor: a case report and literature review;Frontiers in Medicine;2024-04-17